Skip to Site Navigation Skip to main content

Pulmonary Hypertension (PH)

Pulmonary hypertension (PH) is a serious and progressive cardiopulmonary condition disease, defined by an elevation of pulmonary artery pressure.  Optimal management, including medical therapy, depends upon an accurate diagnosis, a dedicated team consisting of knowledgeable physicians and allied healthcare providers, and a familiarity with the available PAH-specific medications, their benefits, and their side effects. Based on Canadian and international expert consensus, it is strongly recommended that PAH patients should be managed at PH centres with demonstrated expertise. 

The McMaster University PH Program at St. Joseph’s Health Healthcare is a Nationally Recognized site of PH excellence. The program specializes in the comprehensive consultative and longitudinal care of patients with all forms of PH. We provide state-of-the-art diagnosis and treatment recommendations, working as a team to review each case thoroughly so as to optimize disease and symptom management. Focus is applied to both clinical excellence and the application of the clinical experience to innovative research projects utilizing both local and national registry data.

The PH program at McMaster strives to advance patient care, research, education, and leadership in the realm of pulmonary vascular disease.